Key stats
About TIGER GLOBAL OBESITY TREATMENT TOP2 PLUS
Home page
Inception date
Feb 29, 2024
Replication method
Physical
ISIN
KR7476690003
The investment trusts constructs an index of listed companies in developed countries that generate revenue or conduct R&D related to obesity treatments, with the top two holdings by market capitalization representing 25% each and the remaining eight holdings weighted by market capitalization
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks100.13%
Health Technology100.00%
Bonds, Cash & Other−0.13%
Cash−0.13%
Stock breakdown by region
North America87.64%
Europe9.56%
Asia2.80%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history